Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Q-FREE - FIRST QUARTER RESULTS 2019

Order intake in the first quarter was very strong. Q-Free has now had six consecutive quarters with order intake growth and a book-to-bill ratio above 1. As a result of the strong order intake in previous quarters, the company delivered 9 percent organic revenue growth in Q1-19. EBITDA was temporarily down because of customer/product mix effects. Highlights for Q1-19 include: * 298 MNOK in order intake, up 47% from Q1-18 * 223 MNOK in revenues, up 9% YoY driven by 25% growth in non-tolling businesses  * 9 MNOK in EBITDA, down from 16 MNOK in Q1-18. IFRS-16 positively impacted

Notice of Extraordinary General Meeting in Bravida Holding AB (publ)

The shareholders in Bravida Holding AB (publ), reg. no. 556891-5390, are summoned to the extraordinary general meeting to be held on Monday 3 June 2019, at 8.30 am at the company’s offices on Mikrofonvägen 28, Hägersten, Sweden. Registration starts at 7.45 amParticipation, etc. Shareholders who wish to participate in the meeting must be recorded in the share register maintained by Euroclear Sweden AB on Monday 27 May 2019, and notify Bravida of their intention to attend the meeting no later than Monday 27 May 2019 by post to Bravida Holding AB (publ), 126 81 Stockholm, Sweden, by

Orkla ASA: Encouraging for Orkla

Orkla's operating profit (EBIT adj) rose by 14% to NOK 1,020 million in the first quarter of 2019. Operating revenues increased by 5% to NOK 10,176 million.  The Branded Consumer Goods business achieved a 10% improvement in operating profit and 0.9% organic sales growth. Orkla Foods had organic growth in most of its markets, while Orkla Confectionery & Snacks achieved improvement in Norway, Finland and Denmark. There was growth in Norway, in particular, due to the reversal of the sugar tax. Orkla Food Ingredients saw an early start to the ice cream season and delivered solid operating

NOHO PARTNERS INTERIM REPORT FOR 1 JANUARY-31 MARCH 2019: Turnover increased by 63 per cent and operating profit by over 198 per cent

NoHo Partners PlcINTERIM REPORT 7 MAY 2019 at 8:00NOHO PARTNERS INTERIM REPORT FOR 1 JANUARY-31 MARCH 2019Turnover increased by 63 per cent and operating profit by over 198 per centTURNOVER AND INCOMEThe Group's Income for January-March of 2019Entire Group:The Group's turnover was MEUR 80.2 (MEUR 49.2), growth of 63.0 per cent. Operating profit was MEUR 2.7 (MEUR 0.9), growth of 198.1 per cent. Earnings per share were EUR 0.14 (EUR 0.03), growth of 367.0 per cent.Restaurant business:The turnover of the restaurant business segment was MEUR 53.3 (MEUR 30.9), growth of 72.4

Kværner ASA: First quarter results 2019: Solid first quarter performance, expects increased annual revenues

7 May 2019 - The results for the first three months in 2019 is the 31[st] quarter in a row where Kvaerner delivers solid, positive results. Per 31 March, the revenues were NOK 2 158 million including joint ventures. The corresponding EBITDA was NOK 137 million, and the EBITDA margin was 6.3 percent. The first quarter ended with a solid order intake of NOK 1 691 million, and an order backlog of NOK 10 196 million. The market is developing positively from the start of 2019. Hence, Kvaerner expects total revenues, including joint ventures, to grow to more than NOK 8 billion for the full year.

Etrion to Release First Quarter 2019 Results on May 8, 2019

May 6, 2019, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX) (OMX: ETX), a solar independent power producer, will release its first quarter 2019 results before the market opens on Wednesday, May 8, 2019.   Operations and Finance Update call   A conference call webcast to present the Company’s first quarter 2019 Operations and Finance update will be held on Wednesday, May 8, 2019, at 8:00 a.m. Eastern Standard Time (EST) / 2:00 p.m. Central European Time (CET).    Dial-in details:  North America: +1-647-788-4991 / Toll Free: +1-877-291-4570 /

Report from Enea AB’s Annual General Meeting 2019

Stockholm, May 6, 2019 Enea (NASDAQ OMX Nordic: ENEA) The annual general meeting of Enea AB (publ) (the "Company"), was held on Monday 6 May 2019, 4.30 p.m. at Kista Science Tower, Färögatan 33 in Kista, Stockholm. The following was decided by the annual general meeting (“AGM”). Adoption of the profit and loss account and the balance sheet The AGM adopted the profit and loss accounts and the balance sheets of the Parent Company and the Group for the financial year 2018. Dividend The AGM resolved that no dividend will be paid. Board of Directors and auditors The AGM

Expressing Creativity – the Felix Schoeller Group presents new products at FESPA 2019

The Felix Schoeller Group, Osnabrück-based manufacturer of high-quality specialty papers, is once again this year taking the opportunity offered by FESPA to present and discuss some exciting new products. This year’s slogan – Expressing Creativity – highlights the numerous creative applications for Felix Schoeller products which visitors will have the opportunity to experience at the company’s stand.S-RACE Photo Panel Pro 120 – a product from the S-RACE Dye sublimation papers segment  A jointly developed product is the outcome of the close business relationship between the Felix

Bulletin from Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)

May 6, 2019 – The Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) took place on Monday, May 6, 2019 in the company´s premises at Tomtebodavägen 23a in Stockholm, Sweden.The complete bulletin from the Annual General Meeting (in the Swedish language) is available on the company’s website, www.indexpharma.com. For more information:Peter Zerhouni, CEOPhone: +46 8 508 847 35E-mail: peter.zerhouni@indexpharma.com  PublicationThe information was submitted for publication through the agency of the contact person set out above at 19:00 CET on May 6, 2019. InDex

Decisions at the Annual General Meeting of Securitas AB (publ) 2019

At today's Annual General Meeting of Securitas AB (publ) the following was resolved:The Annual General Meeting adopted the Statement of Income and the Balance Sheet as per December 31, 2018. The Annual General Meeting discharged the Board of Directors and the President from liability for the financial year of 2018. DividendIn accordance with the proposal of the Board, the Meeting resolved to declare a dividend of SEK 4.40 per share. May 8, 2019 was determined as record date for dividend and payment from Euroclear Sweden AB is expected to commence on May 13, 2019. Authorization of

Endomines’ Annual General Meeting postponed – new date is 10 June 2019

Endomines AB, Stock Exchange Release 6 May 2019 at 18:30 CEST The shareholders in Endomines AB (publ) are hereby notified that the planned Annual General Meeting to be held on 3 June 2019 is postponed giving the Board more time to prepare their proposals to the Annual General Meeting. The new date for the Annual General Meeting will be Monday 10 June 2019. For further information, please contact:Marcus Ahlström, Interim CEO, +358 50 544 68 14, Marcus.ahlstrom(at)endomines.com The information was submitted for publication, through the agency of the contact persons set out above,

Ossur Hf : Transactions in relation to share buyback program

Announcement no. 29/2019 6 May 2019  Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share buyback program is to reduce the Company's share capital and adjust the capital structure by distributing capital to shareholders in line with the Company's Capital Structure and Dividend Policy. The program will end no later than 30 June 2019. The Company may purchase up to 5,000,000 shares under the program, corresponding to 1.2% of the current share capital. The

Nexam Chemical presents the first quarter for 2019 on May 7 at 11:00 CET

Nexam Chemical will publish the interim report for the first quarter 2019 on May 7th, 2019 at 08:00 CET. The report  and the presentation  will be available at the company website.In connection with the release - analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Johan Arvidsson, CEO will present and comment the report. The presentation will be held in Swedish via a conference call or audio webcast at https://

Proposal of board members and remuneration for the annual general meeting in Haldex

Proposal for election of the board of directors and the auditor and resolution on fees for the directors and the auditor (items 10 – 13 on the agenda) Kite Lake Capital Management (UK) LLP, which manages several funds that together are the third largest shareholder in Haldex, proposes the following. Considering that the two largest shareholders, ZF, through its announced acquisition of Wabco, and Knorr Bremse, are the main competitors of Haldex, Kite Lake Capital Management (UK) LLP is making the proposal without consultation with ZF and Knorr Bremse. · the board of directors shall

Annual General Meeting 2019

Stockholm – Tele2 AB (“Tele2”) (Nasdaq Stockholm: TEL2 A and TEL2 B) today announced that the company's Annual General Meeting (AGM) held today voted to support all of the resolutions that the Board of Directors and Nomination Committee proposed to the AGM.The AGM re-elected Andrew Barron, Anders Björkman, Georgi Ganev, Cynthia Gordon, Eva Lindqvist, Lars-Åke Norling and Carla Smits-Nusteling as directors of the Board, and elected Carla Smits-Nusteling as new Chairman of the Board. The AGM re-elected Deloitte as auditor until the end of the 2020 AGM. Pontus Pålsson will continue as

Invitation to Eastnine’s annual seminar

Eastnine welcomes shareholders, representatives from the financial markets and media to our annual seminar in conjunction with the Annual General Meeting. This year, the seminar will be held at Näringslivets Hus, Storgatan 19 in Stockholm, Wednesday 15 May at 13.00-14.30 CET. The Annual General Meeting for shareholders in Eastnine will commence at 15.00 CET. The seminar is open for all. The purpose of the seminar is to present the Company’s development over the last year and our strategic plans, an outlook on the Baltic office property market, and the Company’s ongoing sustainability

Exercise of employee share options in Atea ASA ("the Company")

1. Employees in the Atea Group have exercised 306,251 options.Following the share option exercise the Board of Directors, pursuant to authorisation granted by the Company's Annual General Meeting, has decided to increase the Company's share capital by NOK 306,251 by issuing 306,251 new shares, of par value NOK 1. Following the increase, the Company's share capital is NOK 109,420,389 divided into 109,420,389 shares. The weighted average option exercise price is NOK 52.36. 2. Options exercised by primary insiders 6 May 2019:August Baumann has exercised 70,000 options in the Company,

Share buy-back by Zalaris ASA

On 6 May 2019, Zalaris ASA purchased 1772 own shares on the Oslo Stock Exchange at an average price of NOK 25,4923. Following the purchase Zalaris ASA holds 248.388 own shares, representing ~1,23% of the total outstanding shares. The shares were purchased in accordance with the share buy-back programme announced 12 March 2019, available at www.newsweb.no. This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

#19-891 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

Invitation to presentation of ÅF Pöyry’s interim report January-March 2019

ÅF Pöyry invites investors, analysts and media to an online presentation of the interim report for January - March 2019 on May 15 at 14.00 CEST with Jonas Gustavsson, CEO and Stefan Johansson, CFO.The presentation will be held in English. The webcast link and presentation will be available at www.afconsult.com/en/investor-relations/financial-reports. To participate in the conference call, please dial: Sweden: +46 (0)850692180USA: +16315107495UK: +44 (0)2071 928000 Confirmation code: 5997264 ÅF Pöyry's interim report for January - March 2019 will be published on May 15 at 11.

Methenamine hippurate EQL Pharma approved

The pharmaceutical Methenamine hippurate EQL Pharma, tablet 1g, has been approved for sale by the Medicine Products Agencies in Sweden, Denmark and the United Kingdom. In the UK, the product will be licensed to a local partner, Advanz Pharma Corp.Methenamine hippurate EQL Pharma is a pharmaceutical that is taken as a prophylaxis against recurrent urinary tract infections. Methenamine hippurate EQL Pharma contains methenamine, a substance that has been registered in Sweden since 1973. Methenamine hippurate EQL Pharma becomes the first and only generic available on the markets where it is

There are no items matching the current filter
There are no more items matching the current filter
Back to top